Personalized Obesity Treatment Systems through Synergistic Combinations

This inventive concept integrates a steroid sulfatase inhibitor composition with cutting-edge technologies like AI, IoT, and blockchain to create a personalized obesity treatment system, enhancing treatment efficacy and patient outcomes.

The original patent disclosed a composition for preventing or treating obesity or lipid-related metabolic disorders. However, it had limitations in terms of personalized treatment and data management. This new inventive concept addresses these limitations by combining the composition with advanced technologies to provide a more effective and tailored treatment approach.

The system consists of a wearable device for monitoring vital signs, a machine learning module for predicting treatment efficacy, and a composition comprising a steroid sulfatase inhibitor for administering a tailored dosage to a subject. The blockchain-based health data management system ensures secure and decentralized data storage, while the machine learning module optimizes lipid metabolism and predicts treatment outcomes. The wearable device and smart pill enable real-time monitoring and personalized treatment regimens.

The new claims introduce a synergistic combination of a steroid sulfatase inhibitor composition with AI, IoT, and blockchain technologies, providing a novel and non-obvious approach to personalized obesity treatment. The integration of these distinct technologies creates a more powerful system that enhances treatment efficacy and patient outcomes.

Alternative embodiments may include integrating the composition with other technologies like augmented reality or 5G networks. Variations may involve using different types of sensors or machine learning algorithms to optimize treatment outcomes.

This inventive concept has significant commercial potential in the healthcare industry, particularly in the fields of obesity treatment, lipid metabolism, and personalized medicine. The target market includes pharmaceutical companies, healthcare providers, and patients seeking more effective and personalized treatment options.